Press release

Notification of Full Year Results Date

6 April 2017

e-Therapeutics plc (AIM: ETX), the drug discovery company, will announce its full year results for the year ended 31 January 2017 on Wednesday, 19 April 2017.

Tags
Share
Sign up for press releases

Discover

Whats New?

Explore more

Tangram Therapeutics Announces Progression to Patient Cohorts in Phase 1/2 RESTORE-MASH Trial of TGM-312 and Appointment of Dr Sonya Montgomery as Chief Development Officer

Sep 3, 2026

Tangram Therapeutics Announces Appointment of Laura Roca-Alonso, Ph.D. as Interim Chief Executive Officer

Mar 30, 2026

Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine

Mar 5, 2026

Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate

Nov 26, 2025

Tangram Therapeutics to Participate in Upcoming Investor and Scientific Conferences

Oct 3, 2025

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Oct 1, 2025

/